Guided Therapeutics (GTHP) Operating Leases (2019 - 2026)
Guided Therapeutics (GTHP) posted Operating Leases of $696000.0 for Q4 2025, up 569.23% sequentially from $104000.0 in Q2 2025, and up 1320.41% YoY from $49000.0 in Q4 2024.
Guided Therapeutics (GTHP) Operating Leases (2019 - 2026) Analysis & Trends
Guided Therapeutics has reported Operating Leases for 7 years, with the latest figure at $696000.0 in Q4 2025.
- Quarterly Operating Leases rose 1320.41% year-over-year to $696000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $696000.0 (up 1320.41% YoY) and the FY2025 annual result came in at $696000.0, up 1320.41% from the prior year.
- Operating Leases climbed to $696000.0 in Q4 2025 per GTHP's latest filing, from $104000.0 in the prior quarter.
- Over five years, Operating Leases peaked at $696000.0 in Q4 2025 and troughed at $20000.0 in Q1 2025.
- A 5-year average of $262000.0 and a median of $267000.0 in 2022 frame the typical range for Operating Leases.
- The sharpest annual moves came in 2021 and 2025: Operating Leases jumped 4080.0% in 2021, then tumbled 91.11% in 2025.
- Over 5 years, Operating Leases stood at $325000.0 in 2021, then changed by 0.0% to $325000.0 in 2022, then slipped by 24.31% to $246000.0 in 2023, then slumped by 80.08% to $49000.0 in 2024, then soared by 1320.41% to $696000.0 in 2025.
- According to Business Quant data, Operating Leases over the past three periods registered $696000.0, $104000.0, and $20000.0 for Q4 2025, Q2 2025, and Q1 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | Guided Therapeutics | 26.06 Mn | 26.05 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 683,000.00 |
| Dec 31, 2025 | 696,000.00 |
| Jun 30, 2025 | 104,000.00 |
| Mar 31, 2025 | 20,000.00 |
| Dec 31, 2024 | 49,000.00 |
| Sep 30, 2024 | 76,000.00 |
| Jun 30, 2024 | 104,000.00 |
| Mar 31, 2024 | 225,000.00 |
| Dec 31, 2023 | 246,000.00 |
| Sep 30, 2023 | 267,000.00 |
| Jun 30, 2023 | 202,000.00 |
| Mar 31, 2023 | 225,000.00 |
| Dec 31, 2022 | 325,000.00 |
| Sep 30, 2022 | 267,000.00 |
| Jun 30, 2022 | 360,000.00 |
| Mar 31, 2022 | 307,000.00 |
| Dec 31, 2021 | 325,000.00 |
| Sep 30, 2021 | 343,000.00 |
| Jun 30, 2021 | 419,000.00 |
| Mar 31, 2021 | 418,000.00 |